Cleared Traditional

K930070 - HEMOCARD HEMOGLOBIN E

K930070 is the FDA 510(k) clearance for HEMOCARD HEMOGLOBIN E by Isolab, Inc.. It is a Class 1 Hematology device (product code CKA) cleared through the Traditional 510(k) pathway after a 92-day FDA review.

K930070 · Isolab, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1993
Decision
92d
Days
Class 1
Risk

K930070 is an FDA 510(k) clearance for the HEMOCARD HEMOGLOBIN E. Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by Isolab, Inc. (Akron, US). The FDA issued a Cleared decision on April 8, 1993 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.1030 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Isolab, Inc. devices

Submission Details

510(k) Number K930070 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 1993
Decision Date April 08, 1993
Days to Decision 92 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 113d · This submission: 92d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 98
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K930070.
STANBIO ALT/GPT (LUQUI-UV) TEST SET
K941314 · Stanbio Laboratory · Jul 1994
LIQUID ALT(SGPT) REAGENT SET
K941287 · Pointe Scientific, Inc., · May 1994
ALANINE AMINOTRANSFERASE (ALT) TEST
K935180 · Em Diagnostic Systems, Inc. · Jan 1994
OLYLMPUS ALANINE AMINOTRANSFERASE REAGENT
K925339 · Olympus Corp. · Feb 1993
ALT (GPT) - ALANINE AMINOTRANSFERASE
K923510 · Randox Laboratories, Ltd. · Nov 1992
ROCHE REAGENT FOR ALT
K924245 · Roche Diagnostic Systems, Inc. · Oct 1992